Better Marijuana Stock: The Green Organic Dutchman vs. Innovative Industrial Properties

Which stock wins in a matchup between these two cannabis companies?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

This article was originally published on Fool.com

If you’re highly skeptical of the multibillion-dollar market caps of some of the most well-known marijuana stocks, there are other alternatives. Two that immediately jump to mind are The Green Organic Dutchman (NASDAQOTH:TGODF) and Innovative Industrial Properties (NYSE:IIPR). The former sports a market cap of a little less than $1 billion, while the latter claims a much smaller market cap of just shy of $400 million.

Innovative Industrial Properties has performed better so far in 2018 and with much lower volatility than The Green Organic Dutchman. But which of these two marijuana stocks is the better pick for investors now?

Marijuana growing in a greenhouse.

IMAGE SOURCE: GETTY IMAGES.

The case for The Green Organic Dutchman

You could argue that a big reason to buy The Green Organic Dutchman (TGOD) stock is that the company has already weathered its worst headwinds. Big partner Aurora Cannabis opted not to exercise an option to buy a bigger stake in TGOD last month. The company’s initial public offering (IPO) stock lock-up period expired last week without a big sell-off. And the huge sell-off of marijuana stocks as Canada’s legal recreational marijuana market opened appears to be over.

With these problems behind it, what are the positive factors to buy TGOD stock? For one thing, the company should be able to sell every gram of cannabis it can produce for a while to come. As many predicted, there were widespread product shortages in Canada as the country’s recreational marijuana market opened.

As of now, TGOD can’t produce any cannabis. However, the company expects to complete its Ontario and Quebec facilities in the first half of 2019. Together, these two facilities will enable TGOD to produce 156,000 kilograms annually. Add to that total another 14,000 kilograms from its Jamaica facility that should be ready to go by the end of this year.

One competitive advantage for TGOD is that it’s one of only two certified organic cannabis producers in Canada. This should give the company an edge with customers who prefer organic products. Also, organic products command premium prices.

TGOD is gearing up to compete internationally as well. The company owns nearly half of Jamaican cannabis company Epican, which has already opened one dispensary in the country, with plans to launch four more. TGOD wholly owns HemPoland, a Poland-based company that markets a well-known cannabidiol (CBD) brand in Europe. In addition, the company has a 50-50 joint venture in Mexico, which is projected to be one of the five biggest international medical marijuana markets outside of the U.S. and Canada.

The case for Innovative Industrial Properties

Why consider investing in Innovative Industrial Properties (IIP)? One reason is the company’s unique business model. IIP is a real estate investment trust (REIT) that provides capital to medical marijuana businesses. The company develops properties for use in producing medical cannabis and then leases the properties to tenants. IIP currently has nine tenants.

Another big plus for IIP is that it focuses on the huge U.S. market. IIP operates in seven states: Arizona, Maryland, Massachusetts, Michigan, Minnesota, New York, and Pennsylvania. Three of these states — Arizona, Massachusetts, and Michigan — should have marijuana markets topping $1 billion by 2022, according to Arcview Market Research and BDS Analytics. 

IIP also has plenty of opportunities to expand. Thirty U.S. states already allow the legal use of medical marijuana. And the medical marijuana markets in the states where the company already operates continue to grow.

Unlike many companies in the cannabis industry, IIP is profitable. It also has a strong balance sheet with no debt. The company’s leases are long term, with a weighted average lease length of 15 years and an average yield on invested capital of 15.7%. This should provide a steady stream of cash flow for IIP.

IIP also stands out from most marijuana stocks in that it pays a dividend. As an REIT, the company must return at least 90% of pretax income to shareholders in the form of dividend payments. IIP’s dividend currently yields an attractive 3.42%. 

Better buy

This decision is, in my view, practically a no-brainer. The Green Organic Dutchman has a market cap of nearly $1 billion with absolutely no revenue. Meanwhile, Innovative Industrial Partners claims healthy and growing revenue and profits. I think that IIP wins over TGOD.

It is important to note that marijuana remains illegal at the federal level in the U.S. This could present problems for IIP in the future. However, my take is that the likelihood of federal antimarijuana policies easing is greater than the likelihood of further restrictions. I think IIP could provide a good way for aggressive investors to profit from the growth in the U.S. cannabis industry.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Keith Speights has no position in any of the stocks mentioned. The Motley Fool US recommends Innovative Industrial Properties. The Motley Fool has a disclosure policy.

 

More on Investing Articles

Investing Articles

After a positive Q4 update, is the Vistry share price set to bounce back?

The Vistry share price has been falling sharply as a result of cost issues in its South Division. But the…

Read more »

Investing Articles

Is it game over for the Diageo share price?

The Diageo share price is showing as much spirit as an alcohol-free cocktail. Harvey Jones is wondering whether he should…

Read more »

Young Caucasian girl showing and pointing up with fingers number three against yellow background
Investing Articles

3 key reasons why AstraZeneca’s share price looks a steal to me right now

AstraZeneca’s share price has fallen a long way from its record-breaking level last year, which indicates that I may be…

Read more »

Investing Articles

Here’s how investors could aim for a £6,531 annual passive income from £11,000 of Aviva shares

As a stock’s yield rises when its price falls, I'm not bothered by Aviva shares’ apparent inability to break the…

Read more »

Investing Articles

3 million reasons why earning a second income is more important than ever

With AI posing a threat to UK jobs, our writer considers ways to earn a second income by investing in…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

With an 8% yield, is the second-largest FTSE 250 stock worth considering?

Our writer considers the value of the second-largest stock on the FTSE 250 with a £4bn market cap and a…

Read more »

Close-up of British bank notes
Investing Articles

10%+ dividend yields! 3 top dividend shares to consider in 2025!

Investing in these high-yield UK dividend shares could deliver a huge passive income for years to come. Royston Wild explains…

Read more »

Bearded man writing on notepad in front of computer
Investing Articles

Greggs’ share price tanked last week. So I bought more!

Could Greggs be one of the FTSE 250's best bargains following its share price slump? Royston Wild thinks so, as…

Read more »